| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.055 | 0.06 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.07 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |